EMVOWA
Live / Registered — Registered (as of 28 Jan 2025)
What this means for you
Registered since 28 Jan 2025. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 28 Jan 2031: the §8 declaration of use).
Record
- Serial number
- 98200367
- Registration number
- 7666773
- Mark type
- Word mark
- Filed
- 27 Sept 2023
- Published for opposition
- 10 Dec 2024
- Registered
- 28 Jan 2025
- Next maintenance filing
- §8 declaration of use, due by 28 Jan 2031 (grace period to 28 Jul 2031)
- Attorney of record
- Mark C. Reichel
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and medical preparations for patients suffering from dysphagia and conditions requiring medication in liquid form for the treatment of viral, bacterial, parasitic and fungal diseases and infections; oral liquid medicines for the treatment of viral, bacterial, parasitic and fungal diseases and infections; drugs for medical purposes in the nature of medicines for the treatment of viral, bacterial, parasitic and fungal diseases and infections; substances, drugs, medicines and medical preparations, namely, drug delivery agents consisting of compounds in the form of oral liquid medicines, oral suspensions, dispersible and soluble tablets, and powders to be consumed in liquid form, that facilitate the delivery of a wide range of pharmaceuticals; substances, drugs, medicines and medical preparations, namely, drug delivery agents consisting of compounds in the form of oral liquid medicines, oral suspensions, dispersible and soluble tablets, and powders to be consumed in liquid form, that facilitate the delivery of anti-infective agents, antineoplastic agents, cardiovascular agents, central nervous system agents, coagulation modifiers, gastrointestinal agents, genitourinary tract agents, psychotherapeutic agents and metabolic agents
Owner
- Rosemont Pharmaceuticals Limited, Leeds, GB
- Rosemont Pharmaceuticals Limited, Leeds, GB
- Rosemont Pharmaceuticals Limited, Leeds, GB
Prosecution history
- 28 Jan 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Jan 2025 — REGISTERED-PRINCIPAL REGISTER
- 10 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Dec 2024 — PUBLISHED FOR OPPOSITION
- 04 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Nov 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Oct 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Oct 2024 — ASSIGNED TO LIE
- 17 Jul 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 04 Jun 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 04 Jun 2024 — NON-FINAL ACTION E-MAILED
- 04 Jun 2024 — NON-FINAL ACTION WRITTEN
- 20 May 2024 — ASSIGNED TO EXAMINER
- 11 Oct 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED